Literature DB >> 9593174

Comparative dispositions of ofloxacin in human head, axillary, and pubic hairs.

K Kosuge1, T Uematsu, S I Araki, H Matsuno, K Ohashi, M Nakashima.   

Abstract

The distribution of ofloxacin (OFLX) along the shaft of each of three hair types, i.e., head, axillary and pubic, was investigated and compared among five healthy male volunteers 1 to 4 months after ingestion of OFLX for 1 or 2 days (total dose, 200 or 600 mg). Five strands of each hair type were sectioned together into successive 0.5-cm lengths starting from the dermal end, over a length of < or = 6 cm, and the OFLX concentration in each hair section was measured by high-pressure liquid chromatography with fluorescence detection. The distribution of OFLX along the head hair shaft was narrow, having a single peak even 3 to 4 months after administration, suggesting a rather uniform growth rate among hair strands. On the other hand, the OFLX distribution along axillary or pubic hair shafts tended to be broad, even having two apparent peaks, and the growth rate did not seem uniform. Since axillary hair seemed to stop growing after having gained a length of < or = 4 to 5 cm, it was suggested to enter a resting stage after the growth of < or = 3 cm over the 2 to 4 months after OFLX incorporation. These findings indicate that head hair is the most suitable for analysis of individual drug use and the larger growth rate and cycle stage variabilities of strands of the other types of hair should be taken into account.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593174      PMCID: PMC105814          DOI: 10.1128/AAC.42.5.1298

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Some aspects of retinal drug toxicity.

Authors:  S J Crews
Journal:  Ophthalmologica       Date:  1969       Impact factor: 3.250

2.  Chloroquine in nail clippings.

Authors:  D Ofori-Adjei; O Ericsson
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

3.  Differences between albino and pigmented rabbit eyes in the intraocular pharmacokinetics of sparfloxacin.

Authors:  M Fukuda; K Sasaki
Journal:  Drugs       Date:  1995       Impact factor: 9.546

4.  Human scalp hair as evidence of individual dosage history of haloperidol: method and retrospective study.

Authors:  T Uematsu; R Sato; K Suzuki; S Yamaguchi; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Possible effect of pigment on the pharmacokinetics of ofloxacin and its excretion in hair.

Authors:  T Uematsu; N Miyazawa; O Okazaki; M Nakashima
Journal:  J Pharm Sci       Date:  1992-01       Impact factor: 3.534

6.  Human scalp hair as evidence of individual dosage history of haloperidol: a possible linkage of haloperidol excretion into hair with hair pigment.

Authors:  T Uematsu; R Sato; O Fujimori; M Nakashima
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

7.  The measurement of ofloxacin in hair as an index of exposure.

Authors:  T Uematsu; N Miyazawa; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  Ofloxacin in human hair determined by high performance liquid chromatography.

Authors:  N Miyazawa; T Uematsu; A Mizuno; S Nagashima; M Nakashima
Journal:  Forensic Sci Int       Date:  1991-10       Impact factor: 2.395

9.  Steady-state pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients: analysis of factors determining their concentrations in hair.

Authors:  T Uematsu; H Matsuno; H Sato; H Hirayama; K Hasegawa; M Nakashima
Journal:  J Pharm Sci       Date:  1992-10       Impact factor: 3.534

10.  Analysis of ofloxacin in hair as a measure of hair growth and as a time marker for hair analysis.

Authors:  N Miyazawa; T Uematsu
Journal:  Ther Drug Monit       Date:  1992-12       Impact factor: 3.681

View more
  4 in total

1.  Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral Therapy.

Authors:  Jillian Pintye; Peter Bacchetti; Sirinya Teeraananchai; Stephen Kerr; Wasana Prasitsuebsai; Thida Singtoroj; Karen Kuncze; Alexander Louie; Catherine A Koss; Chengshi Jin; Nhi Phung; Howard Horng; Annette H Sohn; Monica Gandhi
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-01       Impact factor: 3.731

2.  Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting.

Authors:  Gert Uves van Zyl; Thijs E van Mens; Helen McIlleron; Michele Zeier; Jean B Nachega; Eric Decloedt; Carolina Malavazzi; Peter Smith; Yong Huang; Lize van der Merwe; Monica Gandhi; Gary Maartens
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04       Impact factor: 3.731

3.  Using Lopinavir Concentrations in Hair Samples to Assess Treatment Outcomes on Second-Line Regimens Among Asian Children.

Authors:  Wasana Prasitsuebsai; Stephen J Kerr; Khanh Huu Truong; Jintanat Ananworanich; Viet Chau Do; Lam Van Nguyen; Nia Kurniati; Pope Kosalaraksa; Tavitiya Sudjaritruk; Kulkanya Chokephaibulkit; Narukjaporn Thammajaruk; Thida Singtoroj; Sirinya Teeraananchai; Howard Horng; Peter Bacchetti; Monica Gandhi; Annette H Sohn
Journal:  AIDS Res Hum Retroviruses       Date:  2015-08-26       Impact factor: 2.205

4.  Protease inhibitor levels in hair strongly predict virologic response to treatment.

Authors:  Monica Gandhi; Niloufar Ameli; Peter Bacchetti; Stephen J Gange; Kathryn Anastos; Alexandra Levine; Charles L Hyman; Mardge Cohen; Mary Young; Yong Huang; Ruth M Greenblatt
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.